We’re thrilled to be bringing you this news letter from BIO International Convention in San Francisco, the biggest global gathering in the field. Which is why we’re attending – to advocate for the North – and the greater UK. I am personally thrilled to be presenting the UK’s proposition for life sciences thanks to the  UKTI as part of Bio’s ‘Global Innovation Hubs’ – and you can be sure I’ll be singing about everything we’ve got going on in the North.

We’re attending as part of a Northern Powerhouse delegation together with Redex Pharma Plc, Manchester Science Parks, BioNow and Aptus Clinical.  You can read more here

In further news the NHSA is also pleased to be supporting the North East’s Bright Ideas in Health Innovation Awards – these are excellent awards which support new practices to make a real difference to patients’ lives. We hope to join many of you at the dinner later this month. Read more here 

Dr Hakim Yadi, Chief Executive Officer, NHSA

Cygnus, a real world digital data collection study from people with cognitive impairment and dementia, delivered by IXICO and supported by the Northern Health Science Alliance, has joined the high profile Dementias Platform UK (DPUK).

The four NHS Trusts participating in the project have now initiated enrolment in the mehealth® digital technology platform which is being deployed for data collection and management. Consumer wearable devices containing accelerometers will also be deployed to collect information on sleep and activity.  The Cygnus study aims to advance the development of digital healthcare in patients with cognitive impairment and dementia and their caregivers.

By joining Dementias Platform UK, Cygnus is now part of a high profile collaborative project that includes leading academic centres and pharmaceutical companies GSK, AstraZeneca and Johnson & Johnson.  IXICO’s mehealth® platform is being used for data collection from participating services and patients and their caregivers.

Read more here